Azacitidine combined with gemtuzumab ozogamicin in patients with relapsed/refractory acute myeloid leukemia

Leuk Lymphoma. 2011 May;52(5):913-5. doi: 10.3109/10428194.2010.551570. Epub 2011 Mar 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aminoglycosides / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Azacitidine / therapeutic use
  • Gemtuzumab
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Middle Aged
  • Remission Induction / methods
  • Retrospective Studies
  • Salvage Therapy / methods
  • Young Adult

Substances

  • Aminoglycosides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Gemtuzumab
  • Azacitidine